It considers if they are safe and work well enough for wider use in the NHS. The following areas of work are accepting stakeholders by invitation only. If you are interested in being involved in one ...

Collaboration and proactive engagement with NHS stakeholders will be crucial to ensure continued access to innovative treatments and maintain the quality of patient care. Emphasising patient care and ...

The Call for Evidence attracted submissions from over 100 NHS stakeholders, including many Royal Colleges, patient organisations and public health institutes. This was followed by an Evidence Hearing ...

Unfortunately this has confirmed that the medicines are not currently cost effective and the committee’s recommendation remains that they should not be provided on the NHS at this time. Today’s draft ...